VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $298,290 | -99.8% | 48,900 | +86.4% | 0.00% | – |
Q1 2021 | $123,549,000 | +23.3% | 26,231 | +87.2% | 0.00% | – |
Q4 2020 | $100,165,000 | -33.0% | 14,009 | 0.0% | 0.00% | – |
Q3 2020 | $149,476,000 | -15.5% | 14,009 | 0.0% | 0.00% | – |
Q2 2020 | $176,793,000 | +37.9% | 14,009 | 0.0% | 0.00% | – |
Q1 2020 | $128,182,000 | -96.9% | 14,009 | -95.2% | 0.00% | -100.0% |
Q4 2019 | $4,100,966,000 | -23.8% | 293,976 | -6.1% | 0.00% | -25.0% |
Q3 2019 | $5,385,371,000 | -36.2% | 312,921 | +0.9% | 0.00% | -33.3% |
Q2 2019 | $8,440,433,000 | +47.3% | 310,082 | +3.6% | 0.01% | +50.0% |
Q1 2019 | $5,730,402,000 | +94.8% | 299,394 | -4.3% | 0.00% | +33.3% |
Q4 2018 | $2,941,251,000 | -53.7% | 312,899 | -6.8% | 0.00% | -40.0% |
Q3 2018 | $6,350,895,000 | -0.9% | 335,671 | +2.4% | 0.01% | 0.0% |
Q2 2018 | $6,405,798,000 | +27.6% | 327,830 | +22.7% | 0.01% | +25.0% |
Q1 2018 | $5,018,847,000 | +12.7% | 267,102 | -0.4% | 0.00% | 0.0% |
Q4 2017 | $4,451,373,000 | – | 268,155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |